CNR Institutional Research Information System

SINI, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 326
AS - Asia 176
EU - Europa 81
Totale 583
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 326
SG - Singapore 159
IT - Italia 50
CN - Cina 13
FI - Finlandia 12
NL - Olanda 7
IE - Irlanda 5
AT - Austria 4
GB - Regno Unito 2
HK - Hong Kong 2
KR - Corea 2
DE - Germania 1
Totale 583
Salva come PNG Salva come JPEG
Città #
Santa Clara 295
Singapore 118
Helsinki 12
Guangzhou 10
Sala Baganza 8
Cavallino 5
Dublin 5
Amsterdam 4
Sassari 4
Vienna 4
Boardman 3
Milan 3
Assemini 2
Hong Kong 2
Naples 2
Phoenix 2
Satriano 2
Seoul 2
Terralba 2
Turin 2
Falkenstein 1
Forest City 1
London 1
Olbia 1
Saronno 1
Totale 492
Salva come PNG Salva come JPEG
Nome #
Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma 28
Genetic Instability Markers in Cancer 17
Germline and somatic NGS-based analysis on BRCA-related tumors 12
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors 11
Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population 11
Genetic and molecular alterations in pancreatic cancer progression by next generation sequencing 11
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 10
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective 10
Il CSCC: aspetti distintivi della patologia 9
BRAF testing techniques in the management of patients with advanced malignant melanoma: a real world comparative study 8
Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond 8
Liquid biopsy in clinical oncology 8
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy 8
null 7
Female Adnexal Tumors of probable Wolffian Origin (FATWO): a case series with next-generation sequencing mutation analysis 7
Different pathogenetic mechanisms are underlying molecular alterations in fanconi and mismatch DNA repair genes among patients with colorectal carcinoma 6
Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations 6
BRCA1 and BRCA2 mutation analysis in breast cancer families from Sardinia 6
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 6
Origin and distribution of the BRCA2-8765delAG mutation in breast cancer 6
Analysis of the MAPK-ERK gene Pathway in primary and metastatic melanoma cell lines 6
Mammary-like adenocarcinoma of the vulva: a rare case report with next generation sequencing 6
BRCA1 and BRCA2 mutation analysis through an evaluation clinic program among Sardinian breast cancer patients. 6
Genetic and epigenetic alterations of mismatch repair genes in endometrial and colorectal carcinomas 6
Identification of candidate transcripts at chromosomes 10q25-q26 and 9p21 in endometrial cancer (EC) and malignant melanoma (MM). 6
Comparison of BRAF testing techniques in patients with advanced malignant melanoma: a real-life study. 6
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach 6
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 6
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 6
Long non-coding RNA CASC2 in human cancer 6
Multiple primary melanomas from same patients present discrepant somatic alterations in main candidate genes 5
Microsatellite instability in melanocytic skin lesions (benign nevi, dysplastic nevi, and primary melanomas along with their metastases) 5
Functionals interactions of the MAPK-ERK gene pathway in melanoma pathogenesis. 5
nalysis of Fanconi anemia genes in colorectal cancer. 5
A Functional Mammalian Target of Rapamycin Complex 1 Signaling Is Indispensable for c-Myc-Driven Hepatocarcinogenesis 5
Genetic alterations in main candidate genes during melanoma progression. 5
Molecular classification for the management of melanoma patients. 5
Pattern and distribution of BRAF/NRAS and P16CDKN2A mutations among primary an secondary lesions in melanoma patients [abstract]. 5
Progetto Alternanza scuola lavoro 2016 - Liceo Scientifico G.Marconi di Sassari 5
Vitamin D status and risk for malignant cutaneous melanoma: recent advances 5
Chromosomal abnormalities and microsatellite instability in sporadic endometrial cancer 5
Comparison of multiple tumor lesions from the same melanoma patients using next-generation sequencing (NGS) approaches 5
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? 5
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy 5
BRAF-NRAS mutation analysis among primary tumors and metastases at different sites from patients with melanoma 5
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas 5
Identification of a novel candidate gene, CASC2, in a region of common allelic loss at chromosome 10q26 in human endometrial cancer. 5
Downregulation of the CASC2a gene in endometrial cancer. 5
Multiple molecular pathways in melanomagenesis: Characterization of therapeutic targets 5
Mutations in main candidate genes (egfr, kras, braf) among patients with non-small-cell lung cancer from Sardinia 5
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma 5
Genetic alterations in main candidate genes during melanoma progression 5
CORRELATION BETWEEN ARGINOSUCCINATE SYNTHETASE (ASS) EXPRESSION AND TREATMENT WITH ARGININE DEIMINASE (ADI) IN MELANOMA CELL LINES. 5
Anti-tumor activity of NBD peptide in melanoma mouse model. 5
Analyses of key-regulator genes in melanoma susceptibility and pathogenesis among patients from south Italy. 4
Impact of tissue type and content of neoplastic cells in the specimen on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma. 4
Expression of arginino-succinate synthetase (ASS) and response to arginine deiminase (ADI) treatment in a series of melanoma cell lines. AACR-NCI-EORTC 4
Squamous cell carcinoma arising in mature cystic teratoma of the ovary: Report of two cases with molecular analysis 4
Germline mutations of hMSH2 and hMLH1 genes in Sardinian patients with colorectal cancer 4
Cytogenetic assesment of the involvement of a new locus at 9p21 in malignant melanoma. 4
Epidemiological and genetic factors underlying melanoma development in Italy 4
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas 4
BRCA1 and BRCA2 analysis in Sardinian breast cancer families 4
Ngs-based analysis of atypical deep penetrating nevi 4
Identification of a novel candidate gene, MENC, in a consensus region of allelic deletion at chromosome 10q26 in human endometrial cancer. 4
Induction of arginosuccinate synthetase (ASS) expression affects the antiproliferative activity of arginine deiminase (ADI) in melanoma cells. 4
CDKN2A and MC1R analysis in amelanotic and pigmented melanoma 4
Idiopathic pulmonary fibrosis (IPF) and lung cancer 4
Molecular analysis of Fanconi anemia (FA) and mismatch repair (MMR) genes in patients with colorectal carcinoma 4
Distribution of the BRCA2-8765delAG mutation in breast cancer in mediterranean area. 4
A novel candidate gene in human endometrial cancer at chromosome 10q26 4
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study 4
Mutation analysis of candidate genes in familial cases with malignant melanoma: identification of an additional susceptibility region at chromosome 9p21 4
Role of Fanconi, MAPK, and p16CDKN2A gene pathways into the pathogenesis of melanoma. 4
NEMO-binding domain peptide inhibits proliferation of human melanoma cells. 4
Cytogenetic analysis at chromosome 9p21 on tissue sections from patients with malignant melanoma 4
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma 4
Molecular alterations at chromosome 9p21 in melanocytic nevi and melanoma. 4
Mutation frequency in BRAF and NRAS genes among primary tumors and different types of metastasis from melanoma patients 4
Genotoxic effects of cadmium chloride on human amniotic fluid cells cultured in vitro 4
Role of argininosuccinate synthetase (ASS) expression in response to arginine deiminase (ADI) in melanoma cell lines 3
Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy 3
Genetic alterations at chromosome 9p21 and melanoma progression. 3
Proteomics and expression analysis for identification of new candidate genes in melanoma progression 3
Fanconi genes may contribute to melanoma pathogenesis. 3
Germline mutations in Brca1 and Brca2 genes among Sardinian breast cancer patients 3
Fanconi genes are altered in subsets of patients with sporadic colorectal carcinoma. 3
Sequential accumulation of molecular alterations at the chromosome 9p21 during development and progression of melanoma. 3
Identification of predictive factors for the occurrence of predisposing MLH1 and MSH2 germline mutations among Sardinian patients with colorectal carcinoma 3
Assessment of germline and somatic alterations in main candidate genes among patients with multiple primary melanoma 3
Mutation analysis of candidate genes in melanoma-prone families: Evidence of different pathogenetic mechanisms at chromosome 9P21 3
Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy 3
Epidemiological features and prognostic parameters of multiple primary melanomas in CDKN2A-mutations patients 3
Overexpression of h-prune in breast cancer is correlated with advanced disease status 3
Spectrum and prevalence of somatic mutation in BRAF and NRAS genes among primary melanomas and their metastases at different anatomical sites 3
Prevalence of BRAF and NRAS mutations in primary tumours and different types of metastasis among melanoma patients 3
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 3
Progressive alterations at chromosome 9P21 in melanomagenesis 3
Germline mutations in candidate genes among patients with cutaneous melanoma from Sardinia. 3
CASC2a gene is downregulated in endometrial cancer. 3
Totale 539
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.211
article - articoli 2.435
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 82
Totale 5.728
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202421 0 0 0 0 0 0 0 0 4 0 13 4
2024/2025597 17 8 109 70 310 83 0 0 0 0 0 0
Totale 618